SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
4024Message 20388710 Overjoyed that we're getting there. It's the biotech scaram(o)uche8/7/2004
4023Yecho. Maybe I'll just stay inside. :-) Yeah, Steve, it's a clean beascaram(o)uche8/6/2004
4022You at the beach, Biomaven in Africa, can't find a European to save your lifsjemmeri8/6/2004
4021Yeah, we're on the same page. But I'm going to look for the potential escaram(o)uche8/6/2004
4020The link didn't work because of the '?' I put after it. Here's wsjemmeri8/6/2004
4019Steve.... strange, but I can't follow your internal link. First time I&#scaram(o)uche8/6/2004
4018I suppose one downside to such weak pricing is how soon they are going to need msjemmeri8/6/2004
4017No doubt there's no 'bubble' in sight. Do you agree with my commentssjemmeri8/6/2004
4016A not-so weak IPO of a biotech-related company. Being a REIT, I suppose it will sjemmeri8/6/2004
4015very good...... US SEC revokes registrations of 12 small stocks Thursday Augustscaram(o)uche8/5/2004
4014>> Another weak IPO << George pointed at ACAD this week in the T/FIscaram(o)uche8/5/2004
4013Another weak IPO: New River Pharma IPO continues biotech string of weak IPO prisjemmeri8/5/2004
4012<i>The ironic thing is that the companies that are down the most are the oscaram(o)uche8/2/2004
4011U.S. FDA Approves Gilead's Truvada, a One-Tablet, Once-a-Day Fixed-Dose Co-Fscaram(o)uche8/2/2004
4010European Regulators Recommend Wyeth Drug Friday July 30, 1:15 pm ET Wyeth Saysscaram(o)uche7/31/2004
4009That's ok. Today there are so many of them that they trip over each other. scaram(o)uche7/30/2004
4008Gilead gets double-digit earnings bump By Russ Britt, CBS.MarketWatch.com Last scaram(o)uche7/30/2004
4007The Fearful Symmetry In Hedge-Fund Holdings <i>Hedge funds huddle togetheDoc Bones7/30/2004
4006Charles River Laboratories Announces Record Second-Quarter 2004 Results and Incrscaram(o)uche7/28/2004
4005Actelion Q2 net 11.3 mln Sfr, Tracleer sales strong Tuesday July 27, 1:09 am ET scaram(o)uche7/27/2004
4004>> hoping August is a little kinder << The sector leaders were whomscaram(o)uche7/26/2004
4003>>CAMBRIDGE, Mass., July 26 /PRNewswire/ -- TolerRx, Inc. today announced tuck7/26/2004
4002FDA Approves Liquid Formulation of Synagis(R) Monday July 26, 2:52 pm ET - Newscaram(o)uche7/26/2004
4001Cyclacel Announces Postponement of Initial Public Offering <i>Guess we'nigel bates7/26/2004
4000:-) Honest, there are some things I'd rather not revisit. Market cap, 12/1scaram(o)uche7/26/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News